Conteúdo de noradrenalina do hipotálamo e tronco-encefálico de ratos inoculados com Trypanosoma Cruzi

Noradrenaline was assayed fluorimetrically in the hypothalamus and brainstem of rats killed 20 and 32 days after inoculation with the Y strain of T. cruzi (300,000 trypomastigotes i.p.). In these animals and their normal controls the right atrial appendages were submitted to the glyoxilic acid fluorescence technique for the demonstration of noradrenergic nerves. The noradrenaline content of the brain-stem and hypothalamus of the infected animals was not significantly different from that of controls. In the atrial appendages, however, an almost complete noradrenergic denervation was observed. This result indicates that the mechanism involved in neuronal lesion in Chagas'disease discriminates between peripheral and central noradrenergic neurons.O conteúdo de noradrenalina do hipotálamo e do tronco encefálico de ratos controle e inoculados com a cepa Y (300.000 tripomastigotas, i.p.) de Trypanosoma cruzi foi medido pela técnica fluorimétrica de Anton e Sayre. Os animais foram sacrificados 20 e 32 dias depois da inoculação. Para avaliação do grau de desnervação simpática do coração dos animais infectados, a aurícula direita foi observada com microscópio de fluorescência após tratamento histoquímieo pela técnica do ácido glioxílico. O conteúdo de noradrenalina do hipotálamo e do tronco encefálico dos animais infectados não diferiu do medido nos animais controle. Contudo, um quase completo desaparecimento das fibras adrenérgicas foi observado no coração dos animais chagásicos, sugerindo que o mechanismo envolvido na lesão discrimina neurônios adrenérgicos centrais e periféricos

IL28B polymorphisms are markers of therapy response and are influenced by genetic ancestry in chronic hepatitis C patients from an admixed population

Background: IL28B polymorphisms are predictors of therapy response in hepatitis C virus (HCV) patients. We do not know whether they are markers of treatment response in admixed populations or not. Aims: To determine whether IL28B polymorphisms are predictors of therapy response in patients with HCV from an admixed population and are influenced by genetic ancestry. Methods: rs12979860 and rs8099917 were genotyped in 222 HCV patients treated with pegylated interferon and ribavirin. Ancestry was determined using genetic markers. Results: IL28B rs12979860 C/C was associated with sustained virological response (SVR), whereas C/T and T/T were associated with failure to therapy (P = 1.12 x 10(-5)). IL28B rs8099917 T/T was associated with SVR, and G/G and G/T were associated with nonresponse/ relapse (NR/R) (P = 8.00 x 10(-3)). Among HCV genotype 1 patients with C/C genotype, genomic ancestry did not interfere with therapy response. Among patients with rs12979860 T/T genotype, African genetic contribution was greater in the NR/R group (P = 1.51 x 10(-3)), whereas Amerindian and European genetic ancestry contribution were higher in the SVR group (P = 3.77 x 10(-3) and P = 2.16 x 10(-2) respectively). Among HCV type 1 patients with rs8099917 T/T, African genetic contribution was significantly greater in the NR/R group (P = 5.0 x 10(-3)); Amerindian and European ancestry genetic contribution were greater in the SVR group. Conclusion: IL28B rs12979860 and rs8099917 polymorphisms were predictors of therapy response in HCV genotypes 1, 2 and 3 subjects from an admixed population. Genomic ancestry did not interfere with response to therapy in patients with rs12979860 C/C, whereas it interfered in patients with C/T and T/T genotypes. Among HCV genotype 1 rs8099917 T/T patients, genomic ancestry interfered with response to therapy.Fapesb [SUS0001/2011]Fapesp [10/10.549-1